Junghak Kim

Junghak Kim is the interim CEO of RosVivo Therapeutics Inc. Prior to joining RosVivo Therapeutics Mr. Kim was the director of Shinwon Investment and Yuyang DNU in South Korea. Mr. Kim brings many years of executive and investment experiences. He has served as a consultant for several multinational companies and raised over $147 million dollars and has managed multiple mergers and acquisitions for his clients.